The owned content playbook for the AI answer layer.

The research is no longer ambiguous: the structural characteristics of content — not just its existence — determine whether AI systems retrieve and cite it. An analysis of 1.2 million ChatGPT responses by Kevin Indig at Search Engine Land finds that 44.2% of citations come from the first 30% of source content — meaning how your content opens is more commercially significant than its total depth. The Princeton GEO study (Aggarwal et al., NeurIPS 2024) quantifies the specific techniques that increase citation rate and those that reduce it. This playbook translates that evidence into eight executable tactics for pharma brand teams, each structured for real MLR workflows.

The evidence base: what actually improves AI citation rate

Princeton's quantified techniques

The Princeton GEO paper analysed which content interventions increase a source's Position-Adjusted Word Count (PAWC) — a measure of how much text an AI engine extracts from a source relative to its rank. The findings should be the foundation of any GEO content strategy:

• Cite Sources: +115.1% PAWC for rank-5 sources. Adding citations within your content dramatically increases citation rate for pages not already at the top of retrieval rankings. Note: the same technique reduces PAWC for rank-1 sources by 30.3% — so site authority matters when choosing where to apply this.
• Quotation Addition: +42.6% PAWC. Content containing direct quotations from authoritative sources is cited at 42.6% higher rates than equivalent content without them.
• Fluency: +13.2%. Well-written, grammatically precise content outperforms rougher copy — relevant for MLR-reviewed assets that are sometimes over-compressed in final approval edits.
• Statistics inclusion: +9.6%. Content containing quantitative claims is cited more often than equivalent content without numbers.
• Keyword stuffing: −8.7%. Over-optimised content is actively penalised. Dense repetition of brand terms without contextual value degrades citation rate.

Brand mention correlation: the third-party signal

A 75,000-brand study by Ahrefs (December 2025) found that web brand mentions correlate with AI Overviews citation at r = 0.664. YouTube mentions are even stronger at r ≈ 0.737 — the single strongest factor measured. The implication for pharma: journal articles, society presentations, HCP educational content, and video-format medical education are not ancillary to a GEO strategy — they are the primary citation-building mechanism. The Ahrefs correlation data predates the explosion of HCP AI usage but the underlying signal is structural: AI citation follows corroboration across independent sources.

The earned content context

A 2026 citation source analysis by Everything-PR / 5WPR indexing 680 million total AI citations finds Reddit accounts for approximately 40% of ChatGPT citations and Wikipedia for 26 to 48%. Neither of these is a channel pharma operates directly — but the underlying pattern matters: AI systems weight sources that aggregate community consensus and cross-reference. The equivalent for pharma is PMC and society guidelines — cross-referenced, high-authority, community-validated. Publishing in PMC-indexed journals is the pharma equivalent of the Reddit-and-Wikipedia citation gravity that drives consumer AI answers.

The tactic table: 8 moves, impact level, and 60-day checks

Tactic deep-dives

Tactic 1: Brand site PI page restructuring

The prescribing information summary page is the highest-authority content most brands control — and it is consistently under-optimised for retrieval. The structural problem: PI pages are typically formatted as dense PDF tables or as linear narrative prose, both of which retrieval engines parse poorly. The fix is to restructure the web-hosted PI summary as explicitly labelled Q&A pairs reflecting real HCP query language: "What is the recommended starting dose?", "Which patients should not receive this treatment?", "How does this drug interact with CYP3A4 inhibitors?" Each answer should be a concise, self-contained paragraph. Front-load the most specific clinical information within the first paragraph — applying the 44.2% front-loading principle means the first third of every answer section is what LLMs extract and cite, not the whole page.

Tactic 2: MOA explainer pages as structured HTML

Mechanism of action queries are among the highest-volume clinical AI searches. A well-structured HTML explainer — with H2 headings for each major mechanistic step, short paragraphs under each, and anchor links to clinical evidence — is indexed reliably and cited at five times the rate of equivalent PDF content. The summary paragraph at the top of the page functions as the citation unit: it must stand alone as a complete description of the mechanism and include a direct link to the primary clinical evidence. Per the Princeton study, including quantitative claims in the summary ("reduces IL-4Rα signalling by X%") increases citation rate by approximately 9.6%.

Tactic 3: Disease-state glossary with canonical definitions

Glossary pages function as anchor definitions for retrieval engines: when a query involves a clinical term, the engine looks for the clearest authoritative definition of that term. If your brand publishes the most structured definition of a key mechanism or clinical concept in your therapeutic area, it becomes a citation candidate every time that concept appears in a related query. Each definition should be 80 to 150 words — long enough to be substantive, short enough to be retrieved as a self-contained unit. The Princeton Quotation Addition finding (+42.6%) applies directly: embedding a direct quote from a clinical trial or guideline within the definition significantly increases citation probability.

Tactic 4: Structured Q&A for HCPs (modular MLR approach)

The most practical MLR path to a retrieval-optimised HCP FAQ is the modular approach: each Q&A unit is reviewed as a standalone medical information response — equivalent to an approved written medical information reply — and the page is assembled from approved units without requiring new approval for the page as a whole. The 20 to 30 questions should cover the clinical queries your medical information team receives most frequently: dosing edge cases, drug interactions, safety monitoring, patient selection, and direct comparative questions. Each answer should reference the relevant label section. This content structure directly matches what HCP-specialised AI platforms surface in clinical query responses.

Tactic 5: EPAR mirror and optimisation

The European Public Assessment Report is regulatory-authority-published content that requires no new MLR approval, already contains clinical efficacy and safety data, and is indexed in English globally. The May 2026 PharmaGEO public index identifies EMA EPARs appearing in top-cited sources for dermatology and inflammatory disease AI queries in English. The optimisation steps are: ensure the EPAR is directly linked from brand properties and from the brand's PI page; include the EPAR URL in schema markup; and reference the EPAR explicitly in owned clinical evidence summaries. Cross-linking between the owned brand domain and ema.europa.eu increases the probability that retrieval engines surface the regulatory-authority document as the primary safety and efficacy reference — a frame pharma companies can rely on without additional MLR burden.

Tactic 6: Syndication strategy

The Ahrefs correlation data (r = 0.664 for web mentions) operationalises to a specific content placement strategy: publish clinical education content on the 10 to 15 third-party domains most frequently cited by LLMs in your therapeutic area. In atopic dermatitis, those are aad.org, pmc.ncbi.nlm.nih.gov, and aafp.org — domains appearing 168, 94, and 92 times respectively in May 2026 Perplexity source usage. A brand appearing on the same domains that drive the AI answer layer's source pool is structurally building citation gravity rather than relying on owned-domain authority alone. The syndication map starts with a source audit of your TA's current AI answers: which domains are cited, and where is your brand absent?

Tactic 7: Third-party HCP placements

Medical society sites and specialist hubs are the highest-citation-gravity domains for clinical TA queries. In the May 2026 PharmaGEO public index, oncology queries are dominated by nccn.org (218 of ~258 citation uses for lung cancer); dermatology by aad.org (168 uses) and psoriasis-hub.com (70 uses). A brand's presence on these domains — via grant-funded educational content, co-authored clinical guidance, or specialist hub articles — directly feeds the source pool LLMs draw from. Ahrefs finds YouTube mentions show the highest single correlation with AI citation at r ≈ 0.737, making medical education video on society platforms a disproportionately high-return channel.

Tactic 8: Ongoing AI answer monitoring

The citation graph is not stable. Digital Bloom's 2025 LLM visibility report measures 59.3% monthly volatility in the AI citation graph — meaning more than half of cited sources change from month to month. A GEO programme that audits quarterly is flying on instruments that are more than 50% stale. The operational standard for mature GEO programmes is monthly query tracking across the four major engines, with a structured scoring methodology that produces both a performance metric (citation rate, accuracy score) and a compliance record (off-label surfacing incidents, superseded content citations). The same records that drive content optimisation serve the regulatory documentation function described in the companion regulatory article.

The PMC floor — publish there or be invisible

Why PubMed-indexed content is a prerequisite

The May 2026 PharmaGEO public index shows pmc.ncbi.nlm.nih.gov in the top cited sources for every therapeutic area measured: 94 citation uses in atopic dermatitis, 154 in psoriasis. PubMed-indexed publication is the minimum viable GEO citation floor. If clinical evidence for your product is not in PMC, retrieval engines have no path to surface it in response to evidence queries. Ensure key trial publications, post-marketing data, and real-world evidence are PMC-indexed, with quantitative primary endpoint results in the abstract's first 150 words — the front-loading principle applied to the unit LLMs actually retrieve.

Implementation sequencing: where to start

The 30-day quick wins

Not all eight tactics require the same timeline. The fast-path actions — executable within a single MLR cycle — are PI page restructuring (format change of approved text), EPAR cross-linking (no new approval), and schema markup for existing product pages (technical change, no copy approval). These three moves address the core structural retrieval barriers most brand sites carry without requiring new content creation or extended review.

The medium-term build — 60 to 90 days — is MOA explainer pages, disease-state glossary, and structured HCP FAQ. These require MLR approval but follow established non-promotional education pathways. The long-term programme — 90 days and ongoing — is syndication strategy, third-party placements, and monitoring infrastructure. These build the multi-domain corroboration signal that drives sustained citation weight. Apply the Princeton GEO principles throughout: front-load clinical specifics, include quantitative claims with sources, maintain fluency, and cite primary evidence. The keyword stuffing anti-pattern (−8.7%) is a reminder that over-optimisation degrades performance — implement every tactic to serve clinical clarity.

Want a real audit on your brand? Request a sample report or get the full PharmaGEO Playbook.